小児期のトラウマが治療抵抗性うつ病と関連することを解明(Childhood trauma linked to treatment resistant depression)

ad

2026-04-21 カロリンスカ研究所(KI)

カロリンスカ研究所の研究は、幼少期のトラウマ体験が治療抵抗性うつ病の発症と関連することを明らかにした。多数の患者データを解析した結果、虐待やネグレクトなどの早期ストレスを経験した人ほど、標準的な抗うつ治療に反応しにくい傾向が確認された。これは、脳のストレス応答系や神経回路の長期的変化が関与している可能性を示唆する。研究は、患者の背景にある心理社会的要因を考慮した個別化治療の重要性を強調し、早期介入や予防の必要性を示した。精神疾患の治療戦略の見直しに貢献する成果である。

<関連情報>

幼少期の逆境体験と治療抵抗性うつ病 Adverse Childhood Experiences and Treatment-Resistant Depression

Ying Xiong, PhD; Philip Lindersten, BSc; Tong Gong, PhD;et al
JAMA Network Open  Published:March 12, 2026
DOI:10.1001/jamanetworkopen.2026.0222

小児期のトラウマが治療抵抗性うつ病と関連することを解明(Childhood trauma linked to treatment resistant depression)

Key Points

Question Are adverse childhood experiences (ACEs) associated with treatment-resistant depression (TRD) after accounting for unmeasured familial confounding?

Findings In this cohort study of 21 192 twins, each additional ACE exposure was associated with a higher risk of TRD, with associations remaining in co-twin control analyses that controlled for familial confounding. Physical neglect and sexual abuse in particular showed a greater magnitude of associations, with each ACE conferring a higher risk of TRD compared with no ACE.

Meaning The finding that ACEs are associated with increased TRD risk independent of familial factors suggests ACE history may help identify individuals with major depressive disorder at high risk for treatment resistance.

Abstract

Importance Adverse childhood experiences (ACEs) are key risk factors for major depressive disorder (MDD), but their associations with treatment-resistant depression (TRD) remain unclear, particularly after accounting for unmeasured confounding, such as shared genetic and familial environmental factors.

Objective To examine the association between ACEs and TRD while accounting for unmeasured confounding within families.

Design, Setting, and Participants This cohort study used a co-twin control design and was based on 2 Swedish Twin Registry cohorts: the Study of Twin Adults: Genes and Environment (STAGE) and the Young Adult Twins in Sweden Study (YATSS). The sample included twins born from 1959 to 1992 who completed surveys in 2005 to 2006 (for the STAGE cohort) or in 2013 to 2014 (for the YATSS cohort). Both cohorts were linked to Sweden’s National Patient Register and Prescribed Drug Register for follow-up until the end of 2016. Data analysis was conducted from September to November 2024.

Exposure ACEs, which were assessed using 7 yes or no items adapted from the Life Stressor Checklist–Revised: emotional neglect or abuse, physical neglect, physical abuse, sexual abuse, rape, hate crime, and witnessing family violence before age 19 years.

Main Outcomes and Measures TRD, which was defined as MDD diagnosed clinically or meeting the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria based on self-reported symptoms and having had at least 2 antidepressant switches of adequate duration (≥6 weeks) with no more than 14 weeks between consecutive prescriptions.

Results The full cohort included 21 192 twins, among whom 17 814 (10 205 females [57.3%]; mean [SD] age, 32.10 [7.82] years) were included in the main analysis. A total of 5558 individuals (31.2%) reported exposure to at least 1 ACE, and 996 (5.6%) reported 3 or more ACEs. The prevalence of TRD was 1.3% (n = 230) overall. Each additional ACE exposure was associated with increased odds of TRD (odds ratio [OR], 1.69; 95% CI, 1.56-1.84). In co-twin control analyses, the association remained within monozygotic and dizygotic twins (OR, 2.23; 95% CI, 1.30-3.83). Among ACE types, physical neglect (OR, 5.73; 95% CI, 3.75-8.75) and sexual abuse (OR, 5.01; 95% CI, 3.47-7.23) showed the greatest magnitude of associations with TRD.

Conclusions and Relevance In this cohort study, ACE exposure was associated with an increased risk of TRD even after accounting for unmeasured familial confounding. The findings highlight the importance of preventing ACEs and incorporating ACE history into clinical assessment to identify individuals with MDD who may be at elevated risk for treatment resistance.

 

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました